BACKGROUND
It is unclear whether radial compared with femoral access improves outcomes in unselected patients with acute coronary syndromes undergoing invasive management.
METHODS
We did a… (More)
BACKGROUND
Conflicting evidence exists on the efficacy and safety of bivalirudin administered as part of percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome.
… (More)
Early invasive management and combined use of potent antithrombotic drugs have substantially reduced the risk for ischemic events in patients with acute coronary syndrome (ACS), but this came at the… (More)
AIMS
We investigated if acute coronary syndrome (ACS) rather than stable coronary artery disease (SCAD) presentation is an outcome modifier with respect to the duration of dual-antiplatelet therapy… (More)
Acute kidney injury (AKI) is an important complication of both diagnostic cardiac catheterization and percutaneous coronary intervention (PCI). A large body of evidence supports that AKI is related… (More)
BACKGROUND
Multiple scores have been proposed to stratify bleeding risk, but their value to guide dual antiplatelet therapy duration has never been appraised. We compared the performance of the… (More)
The question of when and how intensively patients with deep-venous thrombosis (DVT) can ambulate remains scarcely underlined. The authors evaluated the evolution of DVT by comparing bed rest and… (More)
BACKGROUND
In patients undergoing primary percutaneous coronary interventions (PCI) for ST-segment elevation myocardial infarction (STEMI), the occurrence of Contrast-Induced Nephropathy (CIN) has a… (More)
Acute kidney injury (AKI) is an important complication of iodinated contrast media administration [1]. It particularly occurs after coronary procedures; the reported incidencemaybe ashigh as50%,… (More)
BACKGROUND
Age, estimated glomerular renal function (eGFR), and ejection fraction are preprocedural predictors of contrast-induced acute kidney injury (CI-AKI) after primary percutaneous coronary… (More)